This Member Publications and Presentations article shares information about:
- Abstracts accepted for presentation at the virtual 16th Annual Meeting of ISMPP, June 16-18, 2020.
- Posters presented at the 2020 European Meeting of ISMPP, January 21-22, in London, UK.
- An editorial by ISMPP leadership spotlighting “The Evolving Role and Responsibility of Medical Publication Professionals.”
- A statement by the European Association of Science Editors (EASE) on quality standards related to COVID-19 research.
| For Your Information: EASE Statement on Quality Standards The EASE Statement on Quality Standards points out that EASE members “have noted poor standards of reporting in many studies related to the COVID-19 pandemic,” and it “urges all involved in collecting and publishing data related to the pandemic to adhere to ethical guidelines, and to follow standard reporting guidelines…” Read the full EASE Statement, released April 7, 2020, for more details. |
The Evolving Role and Responsibility of Medical Publication Professionals
An editorial, “The Evolving Role and Responsibility of Medical Publication Professionals,” was co-authored by Robert Matheis, ISMPP President & CEO, and Todd Parker, incoming ISMPP Board of Trustees Chair. The editorial highlights our evolved world in which legacy medical publication professionals now function as medical communication professionals with an expanded remit and responsibilities. Several opportunities are raised that are expected to keep us innovating into the future. The editorial was published in a supplement in Current Medical Research and Opinion (CMRO) on April 20, 2020.
46 Abstracts Accepted for the 16th Annual Meeting of ISMPP
ISMPP is pleased to announce that 46 abstracts were accepted for presentation at the upcoming virtual 16th Annual Meeting of ISMPP, to be held June 16-18, 2020. The abstracts address various relevant topics, including effective communication, plain language summaries, open access, preprints, metrics, and social media. The abstracts were published on April 20, 2020, as a supplement in CMRO. The posters will be available to Society members on ISMPP’s website after the virtual 16th Annual Meeting in June.
| Authorship | ||
| 1 | Authorship decisions for industry-sponsored registry publications: guidance from the literature | Victoria Edwards, Nicky Dekker, Marie Diamond, Satarupa Sen, Rachel Strother, Anna Georgieva, and Jean Williams |
| 2 | Practices around authorship invitation and acceptance | Cindy Busch, Susan Croce, Eleanor Devaney, Nicole Emery, Briana Granese, Barbara Kuri, Stephanie Lit, Monica Salvadore, Nichole Werneking, and Philip Sjostedt |
| 3 | Registration and use of ORCID by pharma (Encore) | Sarah Sabir, Paul Farrow, Matt Buys, Ana Cardoso, James Munday, Tom Rees, and Alice Meadows |
| Contemporary Topics | ||
| 4 | AI-based Manuscript Assessment Tool (MAT) aids in quality check and reduces time to journal submission (Encore) | Trinka D’Cunha, Sharad Mittal, and Pinki Rajeev |
| 5 | Challenges and growth opportunities: the landscape of Chinese medical publication professionals in the global context | Jining Zhang, Yilin Ge, Jiao Wang, Zhihua Wu, Ying Wang, Amit Bhat, and Yutao Lin |
| 6 | Expectations for publication professionals: Results of an online survey | Joseph C. Naggar, Sharon Blimm, Amy Calamari, Aaron Hazzard, and Kristen Lewis |
| 7 | How many zebras are there, and where are they hiding in medical literature? A literature review of publications on rare diseases | Mukund Nori, José L. Walewski, and Dan Donovan |
| 8 | Patient involvement in medical journal editorial processes – disparities in consensus linger | Claudia Piano, Gary Dever, Robert Morgan, and Michael G. Pellegrino |
| 9 | Paving way for transparency in biomedical publications: Where do we stand with the open peer review system? | Shweta Pitre, Priya Ganpathy, Ramji Narayanan, Nigar Malik, Sangita Patil, and Vatsal Shah |
| 10 | Plagiarism detection software – is the net too wide? | Rezan Sahinkaya, William Sinkins, Amanda C. Vreeland, Heidi Reinholdt, Christopher Barnes, Dina Marenstein, and Sandra Harris |
| 11 | Strategies to empower and train internal medical communication colleagues and agency partners in a resource-constrained environment | Susan A. Nastasee, Susan B. Hannah, and Sonia A. Schweers |
| 12 | A survey-based evaluation of experiences with medical device communications | Catherine DeBrosse, Heather Starkey, Natalia Zhukovskaya, Peter Rittenhouse, and Val Injev |
| Effective Communication | ||
| 13 | Challenges and insights on parallel publication of manuscript with conference presentation: A case study | Ramji Narayanan, Priya Ganpathy, Shweta Pitre, Madhavi Patil, and Vatsal Shah |
| 14 | Consumption of publication content—mapping the audience journey to inform omnichannel planning in an open world | Adam Ruth, Ravi Subramanian, Joelle Suchy, Nancy Sladicka, Suzanne Van De Water, Ann Loftus, Beth McGhee, and William Fazzone |
| 15 | Incorporating interactive figures in medical research articles: Challenges and opportunities | John Ashkenas, Derah Saward-Arav, and Maria Haughton |
| 16 | An innovative approach to peer-reviewed publications in the digital era: A case study | Katherine Roberts, Patricia Fonseca, and Christine Lindquist |
| 17 | Poster format preferences among attendees at a major medical congress | Alyssa Bowling, David Cantu, Antonio Meo, Samantha Koth, Edmund Cunningham, and Todd Grinnell |
| 18 | Precision communication in oncology: Are stakeholder needs being met? (Encore) | Karen King and Elaine Wilson |
| 19 | Smart technology: Use of QR codes at conferences | Maria Haughton, Sushmita Roy Nawathe, and John Ashkenas |
| Metrics | ||
| 20 | The citation advantage of promoted articles in a cross‐publisher distribution platform: A 12‐month randomized controlled trial | Paul Kudlow, Devin Bissky Dziadyk, Alan Rutledge, Aviv Shachak, and Gunther Eysenbach |
| 21 | Is there an effect of sponsor involvement on hematological rare disease registry publications’ journal impact factor? | Shweta Rane, Gabriela Marcheva, and Vidya Sagar |
| 22 | A multi-channel approach to assess publication activity and attention: A case study | Eileen Hartman, Lauren Boudewyn, Chelsea Higgins, and Robert Consalvo |
| 23 | Using a ‘value-based’ metric framework for an in-depth assessment of the impact of practice-changing articles shortlisted by NEJM | Avishek Pal, Heather Lang, and Tom Rees |
| Open Access | ||
| 24 | How open are pharma publications? (Encore) | Steph Macdonald and Tim Koder |
| 25 | Importance of open access publishing in the pharmaceutical industry | Christine Coco, MaryKate Lesnevich, Dorothy Zissler, and Gary Brodskiy |
| 26 | Obtaining retrospective open access publishing: A Shire experience (Encore) | Christopher P. Rains, Martin Delahunty, and Valerie Philippon |
| 27 | Online attention and reach of open access industry-sponsored medical publications | Adam Watson, Michelle Kissner, Elizabeth Whann, and Catherine Skobe |
| 28 | Open access publishing at Shire: A quantitative assessment (Encore) | Valerie Philippon, Shailesh Y Desai, Anne Rusk, Slavka Baronikova, and Christopher P. Rains |
| Plain Language Summaries | ||
| 29 | Compliance-related questions and comments about plain language summaries of publications: A thematic analysis | Lauri Arnstein, Dawn Lobban, Hiroko Ebina, and Karen L. Woolley |
| 30 | Could PubMed be a viable route to discovering plain language summaries?(Encore) | Caroline Shepherd, Gemma Fisher, and Jason Gardner |
| 31 | Defining a process for developing and disseminating abstract plain language summaries for scientific congresses: A case study (Encore) | Dheepa Chari, Lauri Arnstein, Sashi Nadanaciva, Cheryl Truchan, Thomas Biegi, Angela Sykes, Simon Stones, Philip Matthews, Hazel Ward, and Margaret Gordon |
| 32 | Developing a company-wide process for publication plain language summaries | Angela Sykes, Dheepa Chari, and J.R. Meloro |
| 33 | Are hematology journals open to publishing plain-language summaries? | Gabriela Marcheva and Shweta Rane |
| 34 | Insights into developing a reading guide to support lay-audience access to clinical-trial manuscripts: What do patients want? (Encore) | Gemma Fisher, Lisa Moore, Lucy Eardley, Adele Blair, and Mary Gaskarth |
| 35 | Patient advocate consultation on plain-language summaries of congress presentations: A case study in oncology | Gunjan Patel, Janelle Landau, Kate Jesien, Dawn Aubel, and Merry Saba |
| 36 | Plain language summaries of publications: Practical ‘how to’ guidance for multi-stakeholder co-creation | Sheila Khawaja, Danielle Derijcke, Begonya Nafria Escalera, Lauri Arnstein, Ify Sargeant, and Anne-Marie Hamoir |
| Preprints | ||
| 37 | Industry-sponsored research on the preprint server medRxiv: The first 6 months | Andy Karalian, Lisa Jolly, and Matthew Booth |
| 38 | The uptake and use of medRxiv | Steph Macdonald, Sarah Sabir, and Tim Koder |
| Real World Evidence | ||
| 39 | Obesity and diabetes publication patterns over 20 years: RCT vs RW/HE publications | Tessa E. Hartog, Patrick Crowley, Patricia Fonseca, Alexandre Houzelle, and Remon Van Den Broek |
| 40 | Scientific reach of the patient voice – patient-reported outcomes in the type 2 diabetes literature | Grace Richmond, Marie Diamond, Rosalie Gadiot, Alexandre Houzelle, and Tessa E. Hartog |
| Standards & Guidelines | ||
| 41 | Data-sharing trends for phase 3 clinical trials in relation to company size | Kevin Ryder and April Suriano |
| 42 | Do top tier journals follow CONSORT recommendations regarding article titles? | Jocelyn Woodcock and Jackie Marchington |
| 43 | A survey of adherence to the International Committee of Medical Journal Editors (ICMJE) recommendations for referencing | Himabindu Gutha, Madhavi Patil, Anupama Singh, Vijay Rayasam, and Vinay Kumar Ranka |
| 44 | Transparency of clinical studies published from the Asia Pacific region – are studies appropriately registered? | Kaushik Subramanian, Amit Bhat, Wenlong Shao, Priyanka Bannikoppa, Rushna Firdaus, and Anuradha Nalli |
| Social Media | ||
| 45 | “To tweet or not to tweet?” The dawn of tweetable abstracts | Jamie L. Kistler, Joanna Willcox, and Nichola Gokool |
| 46 | Social media: How are pharmaceutical companies using it? | Tamalette Loh, Beatrice Vetter-Ceriotti, Mary Gaskarth, Jackie Marchington, and Lynda Chang |
27 Posters Presented at 2020 European Meeting of ISMPP
ISMPP members presented 27 posters at the 2020 European Meeting of ISMPP, January 21-22, covering such key topic areas as digital/social media, open access, patient advocacy, and transparency. ISMPP members can access the posters in the 2020 European Meeting Archive on ISMPP’s website. The abstracts were published on April 20, 2020, as a supplement in CMRO.
| Digital/Social Media | ||
| 1 | Life after publication: Reach and impact in an online era | Stephen J. Griffiths and Christine M. Vanderlinden |
| 2 | The evolution of medical publications in the digital age: Where are we heading? | Nichola Gokool, Martin Vinding, David Sheppard, Dean Martin, Chris Langford, and Paul Trevorrow |
| 3 | Enhanced content to complement traditional publications: A case study of benefits and challenges | Valerie Moss, Rob Campbell, and Neil Venn |
| 4 | Prevalence, visibility and reach of video abstracts on the video sharing platform YouTube* | Maria Haughton |
| 5 | A novel ‘value-based’ metric framework to measure the influence of scientific publications | Avishek Pal, Heather Lang, and Tom Rees |
| Good Publication Practice | ||
| 6 | Perceptions regarding author affiliation on the credibility of scientific articles | Roseanne Girnary, Fran Young, David Gothard, and Eric Southam |
| 7 | Submission systems: A practical analysis | Pablo Pons, William Dolben, and Laura Pérez |
| 8 | AI-based Manuscript Assessment Tool (MAT) aids in quality check and reduces time to journal submission | Trinka D’Cunha, Sharad Mittal, and Pinki Rajeev |
| 9 | Use of ‘subject’ vs ‘participant’ vs ‘patient’ in medical publications – is more guidance needed? | Kim Brown, Anne Rusk, Hajira Koeller, Keith Gaddie, Marianne Jenal-Eyholzer, and Susan Wieting |
| Literature Search | ||
| 10 | Digital therapeutics: Evaluating precision of terminology in published literature | Ben Caldwell, Tony Reardon, Stephen Purver, and Terri Penfol |
| 11 | Evolution of publications on the mucopolysaccharidoses following therapy approval | Emma Conran and Tony Ferrar |
| 12 | Writing up the robots: An analysis of the publication of smartphone-healthcare application trial data | Charlotte Bell, Michael Smith, and Amy MacLucas |
| Medical Communications | ||
| 13 | Precision communication in oncology: Are stakeholder needs being met? | Karen King and Elaine Wilson |
| 14 | Is it time to overhaul the format of scientific posters? | Rebecca Helson, Debbi Gorman, Ben Clarke, Kirsty Okyne, and John Matthew |
| Open Access | ||
| 15 | Reach and impact of pharmaceutical industry-affiliated preprints, and subsequent peer reviewed publications | Susan Wieting, Gina D’Angelo, David Gothard, Lisa Law, Valérie Philippon, Eric Southam, and Heather Lang |
| 16 | Geographic differences in the growth of open access publishing | Marc Lynch, Emma Phillips, and Simon Foulcer |
| 17 | Review of open access (OA) options in the publications of GSK sponsored research | Santosh Mysore, Barbara DeCastro, Aimee Lomas, Rayanta Joshi, Andrew Freeman, and Christine M. Vanderlinden |
| 18 | How open are pharma publications? | Steph Macdonald and Tim Koder |
| 19 | Open sesame! Evaluation of an open access commitment on manuscripts affiliated to a mid-sized pharmaceutical company | Simon Page, Joelle Buck, David Gothard, Heather Lang, and William Gattrell |
| 20 | Open access publishing at Shire: A quantitative assessment | Valérie Philippon, Shailesh Y. Desai, Anne Rusk, Slavka Baronikova, and Christopher P. Rains |
| 21 | Obtaining retrospective open access publishing: A Shire experience | Christopher P. Rains, Martin Delahunty, and Valérie Philippon |
| Patient Advocacy | ||
| 22 | Could PubMed be a viable route to discovering plain language summaries? | Caroline Shepherd, Gemma Fisher, Jolanta Beinarovica, and Jason Gardner |
| 23 | Have patient-focused presentations at scientific congresses increased over time? | Emma Phillips, Julia Stevens, Olivia Wakeman, Debbie Nixon, and Simon Foulcer |
| 24 | Defining a process for developing and disseminating abstract plain language summaries for scientific congresses: A case study** | Dheepa Chari, Lauri Arnstein, Luciano Passador, Thomas Biegi, Simon Stones, Philip Matthews, Hazel Ward, and Margaret Gordon |
| 25 | Insights into developing a reading guide to support lay-audience access to clinical-trial manuscripts: What do patients want? | Gemma Fisher, Lisa Moore, Lucy Eardley, Adele Blair, and Mary Gaskarth |
| Transparency | ||
| 26 | Registration and use of ORCID by pharma | Sarah Sabir, Paul Farrow, Matt Buys, Ana Cardoso, James Munday, Tom Rees, and Alice Meadows |
| 27 | Assessment of the adoption of estimands in the reporting of phase 3 randomised, controlled trials | Graham Allcock, Nikki Kendrick, and Andy Bond |
**Best Reflective of Meeting Theme award
Notify Us of Your Publications and Presentations!
ISMPP encourages members to publish and present research/information related to medical publications and scientific communications to advance the professions and improve standards and best practices. Please contact Anna Geraci, ISMPP Director of Communications, at ageraci@ismpp.org, to share your publications and presentations in The MAP.